Exploring Plasma Coenzyme Q₁₀ Status in Paediatric Dyslipidaemia.

Area of Science:

• Biochemistry
• Pediatric Endocrinology
• Clinical Chemistry

Background:

• Coenzyme Q10 (CoQ) is a vital lipid with diverse biological roles.
• Plasma CoQ status exhibits a strong correlation with cholesterol levels, necessitating simultaneous investigation.
• Dyslipidemias in pediatric patients present a unique context for studying CoQ and lipid interactions.

Purpose of the Study:

• To investigate plasma CoQ concentrations, lipoprotein profiles, and the CoQ/cholesterol ratio in pediatric patients with various dyslipidemias.
• To explore the relationship between CoQ status and different types of dyslipidemias, including hypercholesterolemia, hypertriglyceridemia, and hypobetalipoproteinemia.
• To assess CoQ levels in pediatric patients with liver conditions.

Main Methods:

• Analysis of plasma CoQ using High-Performance Liquid Chromatography (HPLC) with electrochemical detection.
• Quantification of lipoprotein and cholesterol concentrations via standard automated methodologies.
• Recruitment of 60 pediatric patients (7 months–18 years) with diagnosed dyslipidemias.

Main Results:

• Significantly lower CoQ values were observed in patients with hypobetalipoproteinemia and liver cirrhosis.
• Hypercholesterolemic patients showed significantly higher mean CoQ levels compared to controls (1.07 µmol/L vs. 0.63 µmol/L).
• A positive correlation was found between CoQ and total cholesterol (r=0.565) and LDL cholesterol (r=0.610).

Conclusions:

• Plasma CoQ and cholesterol analysis is recommended for pediatric patients with hypobetalipoproteinemia and hypercholesterolemia, especially those with liver involvement.
• CoQ/cholesterol ratios did not differ significantly between hypercholesterolemic patients and controls, or in hypobetalipoproteinemia.
• The study highlights the intricate relationship between CoQ, cholesterol, and lipoprotein metabolism in pediatric dyslipidemias.